NCT01090024 - Bi 671800 in Asthmatic Patients on Inhaled Corticosteroids | Biotech Hunter

Enrollment

108

Participants

Timeline

Start Date

March 1, 2010

Primary Completion Date

February 1, 2011

Study Completion Date

February 18, 2011

Conditions

Asthma

Interventions

DRUG

BI 671800

DRUG

Placebo

Placebo matching BI 671800

Trial Locations (14)

1268.53.01013 Boehringer Ingelheim Investigational Site, Huntington Beach

1268.53.01014 Boehringer Ingelheim Investigational Site, Mission Viejo

1268.53.01002 Boehringer Ingelheim Investigational Site, Stockton

1268.53.01009 Boehringer Ingelheim Investigational Site, Colorado Springs

1268.53.01011 Boehringer Ingelheim Investigational Site, Denver

1268.53.01001 Boehringer Ingelheim Investigational Site, North Dartmouth

1268.53.01005 Boehringer Ingelheim Investigational Site, Minneapolis

1268.53.01006 Boehringer Ingelheim Investigational Site, St Louis

1268.53.01007 Boehringer Ingelheim Investigational Site, Raleigh

1268.53.01010 Boehringer Ingelheim Investigational Site, Portland

1268.53.01003 Boehringer Ingelheim Investigational Site, Charleston

1268.53.01008 Boehringer Ingelheim Investigational Site, El Paso

1268.53.01012 Boehringer Ingelheim Investigational Site, San Antonio

1268.53.01015 Boehringer Ingelheim Investigational Site, Richmond